Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |